Mideast Spy Agencies Nervous Syria May Use Bioweapons

Global Security Newswire Staff
See more stories about...
Global Security Newswire Staff
Sept. 5, 2013, 9:02 a.m.

Middle East­ern in­tel­li­gence of­fi­cials are con­cerned that Syr­i­an Pres­id­ent Bashar As­sad’s re­gime could for the first time de­ploy bio­lo­gic­al weapons in re­tali­ation to an ex­pec­ted U.S. mis­sile strike, the Wash­ing­ton Post re­por­ted on Wed­nes­day.

Syr­ia has nev­er form­ally de­clared a bio­lo­gic­al weapons pro­gram, though it came close last sum­mer to ad­mit­ting own­er­ship of one.

Seni­or-rank­ing spy of­fi­cials from two Middle East­ern na­tions an­onym­ously told the Post that they have stud­ied the pos­sib­il­ity of Syr­i­an bio­lo­gic­al at­tacks in re­sponse to West­ern strikes on the Syr­i­an cap­it­al. The United States is seek­ing to build in­ter­na­tion­al sup­port around lim­ited cruise mis­sile at­tacks on the As­sad re­gime as pun­ish­ment for its widely sus­pec­ted Aug. 21 gas at­tack on Syr­i­an ci­vil­ians in the Dam­as­cus sub­urbs.

“We are wor­ried about sar­in, but Syr­ia also has bio­lo­gic­al weapons, and com­pared to those, sar­in is noth­ing,” one of the in­ter­viewed of­fi­cials said. “We know it, and oth­ers in the re­gion know it. The Amer­ic­ans cer­tainly know it.”

De­tails of Syr­ia’s re­search and de­vel­op­ment of bio­lo­gic­al weapons re­main some­what mys­ter­i­ous. A 2008 ana­lys­is by a Wash­ing­ton think tank con­cluded that the mil­it­ary likely had es­tab­lished the abil­ity to pro­duce, at a min­im­um, botulism and an­thrax.

Jill Bel­lamy van Aalst, a biode­fense ad­viser to NATO, said Syr­ia in re­cent years has ac­quired much phar­ma­ceut­ic­al equip­ment that is “dual use.” Though it may be used for val­id health re­search, the tech­no­logy also could be used to pro­duce patho­gens for weapon­iz­ing, the Post cited her as say­ing.

“You don’t stock­pile bio­lo­gic­al weapons any­more, be­cause today it’s all about pro­duc­tion ca­pa­city — and in Syr­ia the pro­duc­tion ca­pa­city is quite sub­stan­tial,” the biode­fense con­sult­ant said.

Syr­ia re­portedly pos­sesses the equip­ment ne­ces­sary for modi­fy­ing patho­gens in­to aer­o­sol or powder form — the bet­ter for dis­pers­al in mil­it­ary at­tacks. There is dis­agree­ment among U.S. of­fi­cials about just how ad­vanced a po­ten­tial Syr­i­an bio­lo­gic­al at­tack would be.

What We're Following See More »
Clinton Rips Into Trump
6 hours ago

Just a day after Donald Trump called her a bigot, Hillary Clinton delivered a scathing speech tying Trump to the KKK and so-called “alt-right.” This new frontier of debate between the two candidates has emerged at a time when Trump has been seeking to appeal to minority voters, among whom he has struggled to garner support. Calling him “profoundly dangerous,” Clinton didn’t hold back on her criticisms of Trump. “He is taking hate groups mainstream and helping a radical fringe take over the Republican Party,” Clinton said.

Quinnipiac Has Clinton Over 50%
9 hours ago

Hillary Clinton leads Donald Trump 51%-41% in a new Quinnipiac poll released today. Her lead shrinks to seven points when the third-party candidates are included. In that scenario, she leads 45%-38%, with Gary Johnson pulling 10% and Jill Stein at 4%.

Trump Not on Ballot in Minnesota
11 hours ago
Chelsea to Stay on Board of Clinton Foundation
11 hours ago

Is the Clinton family backtracking on some of its promises to insulate the White House from the Clinton Foundation? Opposition researchers will certainly try to portray it that way. A foundation spokesman said yesterday that Chelsea Clinton will stay on its board, and that the "foundation’s largest project, the Clinton Health Access Initiative, might continue to accept foreign government and corporate funding."

Trump on Immigration: ‘I Don’t Know, You Tell Me’
14 hours ago

Perhaps Donald Trump can take a plebiscite to solve this whole messy immigration thing. At a Fox News town hall with Sean Hannity last night, Trump essentially admitted he's "stumped," turning to the audience and asking: “Can we go through a process or do you think they have to get out? Tell me, I mean, I don’t know, you tell me.”